PRESS RELEASE published on 05/28/2024 at 07:30, 1 year 11 months ago BRAIN Biotech AG receives major milestone payment and stays on-track to achieve year end targets BRAIN Biotech AG receives significant milestone payment of € 1.5 million and maintains progress towards year-end goals with strengthened cash position. Half-year results show revenue growth and improved EBITDA Financial Results EBITDA Revenue Growth BRAIN Biotech AG Milestone Payment
PRESS RELEASE published on 05/28/2024 at 07:30, 1 year 11 months ago Evotec and CHDI Foundation extend strategic drug discovery collaboration in Huntington’s disease Evotec SE extends strategic drug discovery collaboration with CHDI Foundation in Huntington's disease, emphasizing commitment to developing new therapies and improving patients' lives Drug Discovery Evotec SE Therapeutics CHDI Foundation Huntington's Disease
PRESS RELEASE published on 05/28/2024 at 07:30, 1 year 11 months ago Inside Information / Other news releases Sensorion announces its participation in upcoming investor conferences in June 2024 to present its novel therapies for hearing loss disorders. The company will attend conferences in New York, Miami, and Lyon Biotechnology Investor Conferences June 2024 Sensorion Hearing Loss Disorders
PRESS RELEASE published on 05/28/2024 at 07:30, 1 year 11 months ago Informations privilégiées / Autres communiqués Sensorion annonce sa participation à des conférences investisseurs en juin 2024. Inscrivez-vous aux événements clés de l'entreprise de biotechnologie spécialisée dans les thérapies de perte auditive Biotechnologie Conférences Investisseurs Événements Sensorion Thérapies Auditives
PRESS RELEASE published on 05/28/2024 at 07:00, 1 year 11 months ago LEM with solid performance for full year 2023/24 in weakening markets LEM announces solid performance for full year 2023/24 despite weakening markets. Sales maintained, EMEA and Rest of Asia grow, China decline. EBIT margin at 20.0%. Dividend proposed at CHF 50 per share Dividend Proposal Full Year Results EMEA Sales Performance LEM
PRESS RELEASE published on 05/28/2024 at 07:00, 1 year 11 months ago Branicks Group launches first fund in new renewables asset class Branicks Group AG launches first fund in new renewables asset class, targeting 8% p.a. returns and EUR 300 million volume Branicks Group AG ESG Renewables Return On Investment Fund Launch
PRESS RELEASE published on 05/28/2024 at 07:00, 1 year 11 months ago Sunrise Medical plans listing on the Frankfurt Stock Exchange Sunrise Medical announces IPO plan to list on Frankfurt Stock Exchange, strengthening growth potential and financial profile in the complex rehabilitation market Financial Performance Frankfurt Stock Exchange IPO Sunrise Medical Rehabilitation Market
PRESS RELEASE published on 05/28/2024 at 07:00, 1 year 11 months ago Informations privilégiées / Autres communiqués Innate Pharma annonce sa participation à des conférences investisseurs mondiales à venir. Détails des conférences et objectif de la société biotechnologique axée sur les immunothérapies contre le cancer Biotechnologie Immunothérapie Cancer Conférences Investisseurs Innate Pharma
PRESS RELEASE published on 05/28/2024 at 07:00, 1 year 11 months ago Description of the regulatory framework of the share repurchase program proposed by the Board of Directors to be approved at Ipsen S.A.’s Annual General Meeting on 28 May 2024 Ipsen S.A. presents the regulatory framework of the share repurchase program proposed at the Annual General Meeting on 28 May 2024, covering objectives, characteristics, maximum repurchase amount, price, and duration Annual General Meeting Share Repurchase Program Regulatory Framework Ipsen S.A. Maximum Repurchase Price
PRESS RELEASE published on 05/28/2024 at 06:45, 1 year 11 months ago EPIC Suisse releases high level Q1 2024 numbers in line with majority shareholder's reporting obligations EPIC Suisse releases high level Q1 2024 numbers in line with majority shareholder's reporting obligations Financial Results EPIC Suisse AG Q1 2024 Majority Shareholder High-level Figures
Published on 05/16/2026 at 01:15, 10 hours 16 minutes ago Findev Inc. Announces a New Member of the Board of Directors
Published on 05/16/2026 at 00:00, 11 hours 31 minutes ago Onco-Innovations Strengthens Quality Testing for Lead PNKP Inhibitor Drug Candidate
Published on 05/15/2026 at 23:10, 12 hours 21 minutes ago Golden Minerals Reports First Quarter 2026 Financial Results
Published on 05/15/2026 at 23:00, 12 hours 31 minutes ago Jericho Energy Ventures Announces Transition to Semi-Annual Reporting to Enhance Efficiency
Published on 05/15/2026 at 20:10, 15 hours 21 minutes ago CPIPG Communication Concerning Voluntary Offer on NEXT RE Shares – Provisional Results Announcement
Published on 05/15/2026 at 18:10, 17 hours 20 minutes ago Virtual Science AI launches first AI-driven competitor activity tracking platform to support pharma asset launch success
Published on 05/15/2026 at 17:33, 17 hours 57 minutes ago Turkiye Garanti Bankasi A.S.: Regarding the Sale of Non-Performing Loans Portfolio
Published on 05/15/2026 at 15:08, 20 hours 23 minutes ago Notice of exercise of early redemption option of the subordinated note ISIN : FR0010203026
Published on 05/15/2026 at 15:00, 20 hours 31 minutes ago Exercice de l’option de remboursement de l'instrument subordonné FR0010203026
Published on 05/15/2026 at 10:09, 1 day 1 hour ago Groupe Crit : Modalités de mise à disposition des documents préparatoires à l’Assemblée Générale Mixte du 05 juin 2026.
Published on 05/14/2026 at 09:03, 2 days 2 hours ago Coup d'envoi pour les carrières dans l'esport : 65% de la population mondiale réclame plus de formations et de parcours professionnels pour le jeu vidéo de compétition
Published on 05/13/2026 at 18:02, 2 days 17 hours ago ALTAREA : Assemblée Générale Mixte du 4 juin 2026 MODALITES DE MISE A DISPOSITION DES DOCUMENTS PREPARATOIRES